Alaunos Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | $22.4M | $71.8M | $68.2M |
| FY2014 | $11.4M | $45.2M | $42.8M |
| FY2015 | $66.4M | $153.7M | $140.7M |
| FY2016 | $58.3M | $106.3M | $81.1M |
| FY2017 | $58.4M | $105.6M | $70.9M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2013 | $22.4M | $71.8M | $68.2M |
| FY2014 | $11.4M | $45.2M | $42.8M |
| FY2015 | $66.4M | $153.7M | $140.7M |
| FY2016 | $58.3M | $106.3M | $81.1M |
| FY2017 | $58.4M | $105.6M | $70.9M |